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p38 mitogen-activated protein kinase plays a pivotal role 
in skin inflammation. The purpose of this study was to 
investigate the role of the various p38 isoforms. p38β/δ-
knockout-C57BL/6 mice were generated, studied in a 
12-O-tetradecanoylphorbol 13-acetate (TPA)-induced 
skin inflammation model and compared with wild-type 
mice. The inflammatory response was determined by 
ear thickness, myeloperoxidase activity and histology. 
mRNA and protein expression of interleukin (IL)-1β and 
IL-6 was determined by quantitative real-time reverse 
transcription PCR and enzyme-linked immunoassay. 
In both groups application of TPA resulted in a signifi-
cant increase in inflammation, and pretreatment with 
the p38α/β inhibitor, SB202190 resulted in a significant 
inhibition. A significantly slower onset but prolonged du-
ration of the response was seen in p38β/δ knockout mice. 
This was paralleled by a significant, but transient, lower 
IL-1β and IL-6 protein expression in p38β/δ knockout 
mice. Although the p38α isoform is important, our data 
also demonstrate an important role of the p38β and/or δ 
isoforms in the regulation of TPA-induced skin inflam-
mation. Key words: p38 MAPK; knockout mice; inflam-
mation; TPA.
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p38 mitogen-activated protein kinase (p38 MAPK) is a 
family member of the mitogen-activated protein kinases, 
which also consists of the extracellular-signal-regulated 
kinases (ERKs) 1 and 2, ERK5 and Jun N-terminal ki-
nases (JNKs) (1).
p38 is activated by environmental stress, such as 
hypoxia, oxidative stress, osmotic shock, heat shock, 
ultra violet (UV) radiation, and pro-inflammatory 
cytokines (1, 2). It mediates inflammatory responses 
through regulation of the gene expression of a number 
of inflammatory cytokines such as interleukin (IL)-1β, 
IL-6 and tumour necrosis factor-alpha (TNF-α) (3). 
This is media tedthrough different regulatory path-
ways, including regulation of mRNA stability and 
translation (4).
Four known isoforms of p38 exist: p38α, p38β, 
p38δ and p38γ (5). Separate genes encode these iso-
forms, which share a high degree of homology at the 
amino-acid level (6–9). In vitro studies have shown 
common substrates, such as activation transcription 
factor-2 (ATF2) and MAPKAP kinase-2 (MK2) for 
p38α and p38β (7), whereas p38γ phosphorylates 
myelin basic protein (MBP) but not ATF2 and MK2, 
and p38δ phosphorylates MBP and ATF2 but not MK2 
(8, 9). Despite a high degree of comparability regarding 
amino-acid sequence and substrate phosphorylation on 
serine and/or threonine residues among the various p38 
isoforms, they differ in tissue distribution and substrate 
specificity and each p38 isoform is therefore believed to 
have a separate and unique function in the cell (6, 8, 9).
p38 activation has been demonstrated in skin inflam-
mation. The p38 as well as the p38α downstream targets, 
mitogen- and stress-activated protein kinase 1 and 2 
(MSK1/2) and MK2 have been found to be activated in 
lesional psoriatic skin compared with non-lesional pso-
riatic skin (10–13). p38 activity has also been demon-
strated to play a role in contact hypersensitivity (14) and 
in burn wounds (15). Thus, the p38 signalling pathway 
exerts both pro- and anti-inflammatory activity.
For instance, we have demonstrated that the p38-ac-
tivated kinases, MSK1 and 2, are critical in controlling 
the skin inflammation induced by 12-O-tetradecanoyl-
phorbol 13-acetate (TPA). These findings demonstrate 
that the p38 signalling pathway plays a dual role in 
regulating both the magnitude and the duration of an 
inflammatory response. 
Only the p38α, -β and -δ isoforms are expressed in 
skin (12, 16). In general, p38α and -β are believed to 
play a role in keratinocytes in response to stress and 
inflammation, whereas activation of p38δ induces ke-
ratinocyte differentiation (17). 
Attempts to discriminate the specific role of the vari-
ous p38 isoforms have been difficult. Most of the avail-
able p38 inhibitors block both p38α and p38β, while 
specific inhibitors of p38γ and δ are not available (18). 
Furthermore, p38α knockout (KO) mouse are embryo-
nic lethal as a result of placental and vascular defects 
(19–21). Mice with a cell type-specific p38α KO have 
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been generated (22), and the role of p38α was studied in 
different skin inflammation models. An important and 
cell-type specific role of p38α was demonstrated. The 
importance of p38α in inflammation has also been de-
monstrated in a collagen-induced arthritis mouse model 
using a chemical genetics approach with knock-in mice 
in which either p38α or p38β was rendered resistant to 
the effect of specific inhibitors (23). 
p38β KO mice have also been generated (24). They 
were shown to have a normal expression and activation 
of p38α in response to cellular stress and a normal 
lipopolysaccharide-induced cytokine production.
Because several studies have demonstrated an important 
role of p38 in inflammation, a thorough understanding of 
the role of the various p38 isoforms in the inflammatory 
response is important. In this study we generated p38β/δ 
double KO mice and studied TPA-induced skin inflam-
mation in these mice compared with matched controls. 
Furthermore, we investigated the role of p38 isoforms in 
the regulation of pro-inflammatory gene expressions at 
both the transcriptional and translational level.
MATERIALS AND METHODS
Mice
The generation of p38β and p38δ mice has been described pre-
viously (24, 25). The double KO of p38β and δ was generated 
by crossing the two individual single KOs. The mice were viable 
and fertile and did not exhibit any obvious phenotype when 
maintained in a pathogen-free environment. Wild-type (WT) 
C57BL/6 mice and p38β/δ KO mice were received from Taco-
nic Europe (Ry, Denmark). Experiments were conducted in the 
animal facility of Aarhus University. After shipment, mice were 
allowed to rest for at least one week before any experiments were 
conducted. All mice used in this study were 7–9 weeks old. In the 
ear measurement and myeloperoxidase studies, female mice were 
used. In the enzyme-linked immunoassay (ELISA), qRT-PCR and 
histology studies, male mice were used. During the experiments 
the animals were fed a standard rodent laboratory diet ad libitum 
and had free access to tap water. They were maintained in animal 
facilities with a temperature of 19–25°C and a 12 h light/dark 
cycle. While challenging the ears, conducting ear measurements 
and obtaining punch biopsies the mice were anaesthetized with 
isoflurane gas, and at the end of the study they were sacrificed 
by cervical dislocation. All experiments were approved by the 
Danish Committee for Animal Experiments.
TPA-induced acute skin inflammation
TPA was purchased from Sigma-Aldrich (St Louis, MO, USA) 
and dissolved in acetone. In a number of experiments p38β/δ 
KO mice and control C57BL/6 mice were challenged with 
TPA (0.125 μg/μl) on the ears (2.5 μg/ear). Vehicle studies 
with acetone alone were also conducted. The p38α/β inhibitor, 
SB202190, was purchased from Lc Laboratories (Woburn, MA, 
USA) and dissolved in acetone. Parallel inhibitor experiments 
with topical application (1 mg/ear) were performed 100 min 
before TPA challenge. Freshly dissolved solutions of both TPA 
and SB202190 were made for each experiment. Before chal-
lenge (0 h) and at different time points post-challenge (2, 5, 8, 
24, 48, 72 h) the ear thickness of the mice was measured using 
a Mitutyo digimatic indicator.
Myeloperoxidase assays
To determine the degree of neutrophil cell infiltration, myeloper-
oxidase (MPO) assays were conducted as described previously 
(26). Four-millimetre punch biopsies were obtained from the 
ears 8 and 24 h post-challenge and frozen immediately in liquid 
nitrogen. Then biopsies were placed in 250 μl 0.5% hexadecyltri-
methylammonium bromide (HTAB) and homogenized (TissueLyser 
from Qiagen, Haan, germany). Homogenates were shaken, incu-
bated at 37°C for 1 h, mixed and centrifuged at 4000 g for 5 min. 
Twenty μl of the supernatant and 100 μl TMB ONE, Ready-to-use 
Substrate (Kem-En-Tec Diagnostics A/S, Copenhagen, Denmark) 
were added to 96-well plates (CM Lab., Vordingborg, Denmark). 
The plates were incubated at room temperature in the dark while 
being gently shaken for 10 min. The reaction was then stopped 
by adding 100 μl 0.2M sulphuric acid (H2SO4). Finally, the MPO 
activity was determined by an ELISA reader (Laboratory Systems 
iEMS Reader MF, Copenhagen, Denmark) at 450 nm.
A standard curve was constructed with human polymor pho nuclear 
cells obtained from blood of healthy volunteers. Poly morphonuclear 
cells were prepared using PolymorphprepTM (AXIS-SHIELD PoC 
AS, Oslo, Norway) according to product instructions. 
Isolation of total protein
In a number of experiments the ears were clipped off after sacrifi-
cing the mice and immediately placed in liquid nitrogen. The ears 
were homogenized in 1× cell lysis buffer (20 nM Tris-Base pH 
7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton-X-100, 
2.5 mM sodium pyrophosphate, 1 mM β-glycerol phosphate, 1 
mM Na3VO4, 1 μg ml
–1 leuleptin and 1 mM phenylmethanesul-
phonylfluoride (PMSF)) using TissueLyser for 2 × 2 min. After 
homogenization the samples were left on ice for 10 min before 
they were sonicated 5 × 10 s. Again the samples were left on 
ice for 10 min and finally centrifuged at 10,000 g for 10 min at 
4°C. The supernatant constitutes the whole-cell protein extract.
Western blotting analysis
Whole-cell protein extracts were prepared from mice ears and 
equal amounts (as determined in Bradford Protein Assay Proto-
col) were separated by sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis (SDS-PAgE) and blotted on to nitrocellulose 
membranes. Membranes were incubated with either anti-p38α/β 
MAPK or anti-phospho-p38α/β MAPK (Cell Signalling Techno-
logy, Beverly, MA, USA) and detected with horseradish peroxi-
dase (HRP)-conjugated anti-rabbit antibody (DAKO, glostrup, 
Denmark) in a standard enhanced chemiluminescence (ECL) 
reaction (Cell Signalling Technology). A Biotinylated Protein 
Ladder Molecular Weight Marker (Cell Signalling Technology) 
was used for estimation of protein size.
Kinase assay
The p38α/β MAPK activity was determined by using a non-
radioactive p38 MAP Kinase Assay Kit according to the 
manufacturer’s instructions (Cell Signalling Technology) and as 
previously described. Briefly, 200 µg of cell lysate was incuba-
ted with 20 µl of immobilized phospho-p38α/β MAPK primary 
antibody overnight at 4°C. The immunocomplexes were isola-
ted and then washed twice with 1 × cell lysis buffer and twice 
with 1 × kinase buffer (25 mM Tris (pH 7.5), 5 mM β-glycerol 
phosphate, 2 mM dithiothreitol (DTT), 0.1 mM NA3VO4, and 
10 mM MgCl2). The pellet was suspended in 1 × kinase buffer 
supplemented with 200 µM adenosine triphosphate (ATP) and 
2 µg of ATF-2 fusion protein and incubated for 30 min at 30°C. 
The reaction was terminated with 25 µl 3 × SDS Sample buffer 
and boiled for 5 min. Twenty-five µl of the sample was loaded 
on SDS-PAGE gel (8–16%).
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ELISA
IL-1β and IL-6 expression levels were measured by ELISA 
using 96-well Maxisorb plates (Invitrogen, Carlsbad, CA, USA) 
and the DuoSet® ELISA Development System (R&D Systems, 
Oxon, UK) according to the manufacturer’s instructions. Brie-
fly, 100 μl diluted Capture Antibody was added to the wells and 
incubated overnight at room temperature. The following day 
the wells were washed before they were blocked for 1 h. The 
plates were incubated with samples and standards for 2 h at room 
temperature before they were washed and incubated at room 
temperature for 2 h with 100 μl diluted Detection Antibody. 
Finally, 100 μl of streptavidin-HRP were added to the wells. 
The streptavidin-HRP incubated at room temperature in the dark 
for 20 min before adding 100 μl of substrate solution (R&D 
Systems) to the wells. The substrate solution was incubated at 
room temperature in the dark for 20 min. Finally, the reactions 
were stopped by adding 50 μl of H2SO4 to each well and im-
mediately hereafter the protein expression was determined in 
doublets by an ELISA reader (Laboratory Systems iEMS Reader 
MF, Copenhagen, Denmark) at 450 nm.
RNA isolation
To determine mRNA expression, 4 mm punch biopsies were 
obtained from the mice ears and immediately frozen and stored 
in liquid nitrogen. Twenty-four hours before RNA extraction 
samples were submerged in 800 μl RNAlater ICE® (Ambion Inc., 
Austin, TX, USA) at –80°C for 20 min, and then stored overnight 
at –20°C. During RNA extraction the biopsies were removed from 
RNAlater ICE® into fresh tubes and 175 μl SV RNA Lysis Buffer 
with β-mercaptoethanol was added (SV Total RNA Isolation 
System, Promega, Madison, WI, USA). The biopsies were then 
homogenized using TissueLyser. The rest of the RNA extraction 
procedure, including DNase treatment, was performed according 
to the manufacturer manual (SV Total RNA Isolation System). 
The RNA content was determined by spectophotometry (Amers-
ham Pharmacia Biotech, Uppsala, Sweden). Samples were stored 
at –80°C until quantitative real-time-PCR was performed.
Quantitative real-time reverse transcription PCR
For reverse transcription (RT) Taqman Reverse Transcription 
Reagents (Applied Biosystems, Foster City, CA, USA) were 
used including the use of random hexamers as primers. The 
production of complementary DNA (cDNA) was carried out 
in a Peltier Thermal Cycler-200 (MJ Research, Inc. Waltham, 
MA, USA) with three consecutive steps: 10 min incubation 
(25°C), 30 min reverse transcription (48°C) and 5 min reverse 
transcriptase inactivation (95°C). The final cDNA was stored at 
–80°C overnight before real-time PCR was performed.
Primers and probes were obtained from Applied Biosystems. 
The mRNA expression of IL-1β and IL-6 were determined with 
Taqman 20X Assays-On-Demand expression assay mix (assay ID: 
IL-1β: Mm00434228_ml, IL-6: Mm00446190_ml). To normalize 
the results we used glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) (assay ID: Mm99999915_gl) as housekeeping gene. 
The probes were 6-carboxy-fluorescein-labelled MGP probes. 
Each gene was analysed in triplicates and the PCR mastermix 
used was Taqman 2× Universal PCR Master Mix, No AmpErase 
from Applied Biosystems. The reactions were carried out in a 
Rotorgene-3000 real-time PCR machine (Corbett Research, 
Sydney, Australia) in a volume of 25 μl. The consecutive steps 
were: 2 min at 50°C, 10 min at 95°C followed by 50 cycles of 
15 s at 95°C, and 60 s at 60°C.
Relative gene expression levels were determined using the 
relative standard curve method (27). Briefly, a standard curve for 
each gene was made of 5-fold serial dilutions of total RNA from 
a punch biopsy obtained from the ear of a control mouse known 
to possess a high RNA content. The curves were then used to 
calculate the relative amounts of target mRNA in the samples.
Histology
Four-millimetre punch biopsies were obtained from the ears of 
C57BL/6 control mice before challenge and three times post-
challenge (5, 8 and 24 h) and immediately fixed in 4% formal-
dehyde. Then they were embedded in paraffin and sliced in 4 
μm thick sections, mounted onto slides and stained with haema-
toxylin and eosin in accordance with standard protocols.
Statistical analysis
The ear thickness data were analysed using a linear mixed effects 
model with treatment, type, time, and the interaction between 
the three as fixed effects. Mouse and ear (within mouse) were 
included in the model as random effects. Correlation between 
measurements on the same ear was taken into account using an 
unstructured autocorrelation structure. 
The MPO, cytokine, and mRNA data were analysed using a 
linear mixed effects model with type, treatment, and time (and 
interactions) as fixed effects. Mouse and the interaction between 
mouse and time were included in the model as random effects. 
Varying residual variation with treatment groups was taken into 
consideration in the statistical analysis.
The appropriateness of the models was evaluated by in-
specting QQ-plots for the residuals and, in the case of the 
ear thickness data, by comparing empirical and theoretical 
autocorrelations. The data were transformed when necessary 
and results are presented as back-transformed means with 95% 
confidence intervals. 
A significance level of 5% was used and the data were ana-
lysed using SAS version 9.2.
RESULTS
TPA-induced p38 activation
In order to demonstrate activation of the p38 signalling 
pathway, ear biopsies from TPA-treated WT mice were 
analysed at various time points by phospho-blotting 
using an antibody recognizing the phosphorylated form 
of p38. An increase in phosphorylation of p38 was seen 
at 0.5 h, reaching a maximum 2 h post-challenge and 
lasting for at least 8 h (Fig. 1a). The increased levels 
of phosphorylated p38 were paralleled by an increased 
kinase activity of p38, as measured by ATF2 phosphory-
lation-induced by immunoprecipitated p38 (Fig. 1b).
Slow onset but prolonged duration of the TPA-induced 
inflammatory response in p38β/δ knockout mice compared 
with wild-type mice
The ears of 12 p38β/δ KO mice and 11 WT mice were 
challenged with 2.5 μg TPA ear–1 to induce an inflam-
matory response. As control, vehicle was applied on 
the ears of 3 KO mice and 6 WT mice. Thickness of 
intact ears was measured before challenge (0 h) and 
2, 5, 8, 24, 48 and 72 h post-challenge. TPA challenge 
induced a significant increase in ear thickness in both 
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p38β/δ KO and WT mice compared with vehicle-
treated mice (p < 0.0001 for the interaction between 
treatment and time). Ear swelling reached a maximum 
8 h after TPA challenge in both KO and WT mice (Fig. 
2). No significant changes in ear thickness were seen 
in vehicle-treated mice (Fig. 2). There was no signifi-
cant difference in ear thickness between KO and WT 
mice at the beginning of the experiment. A test for 
no difference between TPA-treated KO and WT mice 
gave a p-value of 0.005 (2 h: p = 0.01, 72 h: p = 0.02, 
all other time-points had p-values above 0.09). These 
significant differences demonstrate a slower onset but 
a prolonged duration of the inflammatory response in 
KO mice compared with WT mice.
When mice were pretreated with the p38α/β inhibitor, 
SB202190, a significant inhibition (p < 0.0001 for the 
interaction between treatment and time) of the inflam-
matory response was seen in both WT and KO mice 
when measured as increase in ear thickness (Fig. 2). In-
terestingly, a slower onset of the inflammatory response 
was also seen 2 h after TPA application in SB202190 
pretreated KO mice compared with SB202190 pretreated 
WT mice (p = 0.045), and a significant increase in ear 
thickness in SB202190-treated KO mice was seen 24 
h after TPA application when compared with WT mice 
(p = 0.01). No significant difference was seen after 72 h 
(Fig. 2).
To assess the degree of neutrophil 
cell infiltration after TPA-induced in-
flammation, a myeloperoxidase assay 
was performed on punch biopsies from 
mouse ears obtained in a separate set 
of experiments. There was a significant 
increase in neutrophil cell infiltration 
in both p38β/δ KO and WT mice pre-
treated with vehicle and challenged 
with TPA compared with mice pretrea-
ted with vehicle and challenged with 
vehicle (p < 0.0001). This increase was 
seen both 8 h and 24 h post-challenge 
(Fig. 3). No significant differences in 
neutrophil infiltration were seen bet-
ween p38β/δ KO and WT mice after 
vehicle pretreatment followed by TPA 
challenge for 8 and 24 h (8 h: p = 0.702; 
24 h: p > 0.127) (Fig. 3).
In the myeloperoxidase assay perfor-
med on biopsies obtained 8 h post-chal-
lenge, pretreatment with SB202190 
resulted in a significant inhibition of 
neutrophil infiltration in both KO and 
WT mice compared with vehicle plus 
TPA-treated mice (p < 0.0001) (Fig. 
3a). At 24 h post-challenge there was 
a significant reduction in neutrophil 
cell infiltration in WT mice pretreated 
Fig. 1. p38α/β activation in 12-O-tetradecanoylphorbol 13-acetate (TPA)-
induced skin inflammation. (a) Whole-cell protein extract was prepared from 
the mice ears and analysed by Western blotting. Proteins were separated 
on 8–16% gradient gels and blotted onto a nitrocellulose membrane. After 
blotting, the membrane was probed with the indicated antibodies. Equal 
loading was confirmed by incubation with an anti-p38α/β mitogen-activated 
protein kinase (MAPK) antibody. (b) Whole protein extracts (200 μg of 
protein) from the mice ears were prepared for immunoprecipitation of p38α/β 
MAPK. Enzyme activities were determined by an in vitro kinase assay, using 
activation transcription factor-2 (ATF2) as substrate. Kinase reactions were 
prepared for sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAgE), and ATF2 phosphorylation was detected by Western blotting 
using an anti-phospho-ATF2 antibody. This assay shows the phosphorylation 
of the phosphorylated p38α/β isoforms. Representative results of (a) three 
and (b) two separate experiments are shown. 
Fig. 2. Inflammatory response determined by the degree 
of ear swelling in p38 β/δ knockout (KO) mice and wild-
type (WT) mice. 6 WT and 3 KO mice were challenged 
with vehicle. 11 WT and 12 KO mice were challenged 
with 12-O-tetradecanoylphorbol 13-acetate (TPA) (2.5 
µg ear–1). A third set of mice (WT n = 9, KO n = 9) was 
treated topically with SB202190 (1 mg ear–1) 100 min 
prior to TPA challenge. Prior to challenge (0 h) and 2, 
5, 8, 24, 48 and 72 h post-challenge the thickness of 
the intact ears was measured using a Mitutyo digimatic 
indicator. Results are shown as back transformed means 
with 95% confidence intervals. Significant differences 
are marked *p < 0.0001 (compared with vehicle); **p 
< 0.0001 (compared with TPA). Insert: early time-points 
highlighted.
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with SB202190 before TPA challenge compared with 
WT mice treated with vehicle before TPA challenge 
(p = 0.023) (Fig. 3b). No significant difference was 
seen between KO mice treated with either vehicle or 
SB202190 before TPA challenge (p = 0.312) (Fig. 3b).
When mice were pretreated with SB202190 a higher but 
statistically insignificant level of neutrophil cell infiltration 
was seen 24 h after TPA application in p38β/δ KO mice 
compared with matched WT mice (p = 0.122) (Fig. 3b).
To visualize the inflammatory response induced by 
TPA, histological examinations with haematoxylin and 
eosin staining were conducted. In a separate set of experi-
ments three groups of WT mice were given the following 
treatments: one group of mice (n = 3) was pretreated with 
vehicle 100 min before challenged with vehicle. Another 
group of mice (n = 6) was pretreated with vehicle 100 min 
before challenged with TPA. A third group of mice (n = 6) 
was pretreated with SB202190 100 min before challenged 
with TPA. Four-millimetre punch biopsies were obtained 
0, 5, 8 and 24 h post-challenge (Fig. 4). Challenge with 
TPA resulted in a marked increase in dermal infiltrate 
and oedema over time (Fig. 4) compared with the ears of 
mice challenged with vehicle (not shown). Furthermore, 
the inhibitory effect of SB202190 on the inflammatory 
response was also confirmed by histological examination 
(Fig. 4).
TPA-induced IL-1β and IL-6 mRNA expression in p38β/δ 
knockout mice and wild-type mice
To study the mRNA expression profile of pro-inflammatory 
cytokines, quantitative real-time RT-PCR was performed 
on punch biopsies obtained from the ears of the mice.
A significant increase in IL-1β and IL-6 mRNA ex-
pression was seen in both KO and WT mice after TPA 
application (p < 0.0001 at all time-points compared with 
vehicle) (Fig. 5a–f). No significant differences were seen 
in IL-1β and IL-6 mRNA expression between p38β/δ KO 
mice and WT mice. Pretreatment with SB202190 lead to 
an inhibition of both IL-1β and IL-6 mRNA expression 
in both KO and WT mice (Fig. 5a and d). This inhibition 
was highly significant for both IL-1β and IL-6 mRNA 
in WT and KO mice after 2 h (p < 0.0001) whereas the 
inhibitory effect of SB202190 was less pronounced at 
the later time-points (Fig. 5b, c, e and f). 
TPA-induced IL-1β and IL-6 protein expression in p38β/δ 
knockout mice compared with wild-type mice
To characterize some of the cytokines involved in the 
inflammatory response, IL-1β and IL-6 protein expres-
sions were analysed 5, 8 and 24 h post-challenge. 
The induction of IL-1β was significant 5, 8 and 24 h 
after TPA challenge in both KO and WT mice compared 
with the vehicle challenged mice (p < 0.0001 at all time-
Fig. 4. Histological sections obtained from 
wild-type (WT) mice showing the effects of 
12-O-tetradecanoylphorbol 13-acetate (TPA) 
challenge with and without pretreatment with 
SB202190. Haematoxylin and eosin (H&E) 
stained histological sections of WT mice ears 
pretreated with vehicle prior to TPA challenge 
(upper panel, bar = 100 µm) and WT mice 
ears pretreated with SB202190 prior to TPA 
challenge (lower panel, bar = 100 µm). Different 
time points are shown: 0 h (prior to challenge) 
and 5, 8 and 24 h post-challenge. Representative 
transversal sections of mice ears are shown. 
n = 3 for each treatment group.
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Fig. 3. Measurement of neutrophil cell infiltration in p38 β/δ knockout (KO) 
mice and wild-type (WT) mice. Three mice in each group were pretreated with 
vehicle and challenged with vehicle. Ten mice in each group were pretreated 
with vehicle and challenged with 12-O-tetradecanoylphorbol 13-acetate (TPA). 
Five mice in each group were pretreated with SB202190 and challenged with 
TPA. SB202190 was applied topically 100 min prior to TPA challenge. At 8 
h (a) and 24 h (b) post-challenge a 4-mm punch biopsy from the ear of each 
mouse was obtained. Number of neutrophilic cells per 4-mm punch biopsy 
is shown. Statistical results are shown as back-transformed means with 95% 
confidence intervals. Significant differences are marked *p < 0.0001 (compared 
with vehicle); **p < 0.0001 (compared with TPA, 8 h); ***p = 0.023 (compared 
with TPA, 24 h, WT mice).
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points). The IL-1β protein expression was maximal 8 h 
post-challenge (Fig. 6a–c). When SB202190 pretreat-
ment was applied, a significant (p < 0.0036 in all cases) 
reduction in IL-1β protein expression was seen in both 
mouse groups 5, 8, and 24 h post-challenge. Interes-
tingly a statistically significant lower IL-1β expression 
was seen in p38β/δ KO mice compared with WT mice 
8 h after TPA challenge (p = 0.0003). Twenty-four hours 
after TPA challenge no statistically significant difference 
was seen in IL-1β expression between WT mice and 
p38β/δ KO mice (Fig. 6a–c).
Induction of IL-6 was similar to IL-1β induction. TPA-
challenge resulted in a significant increase in IL-6 protein 
expression 5, 8 and 24 h post-challenge in both p38β/δ 
KO and WT mice (p < 0.0001 in all cases compared with 
vehicle). The maximal expression was 8 h post-challenge 
(Fig. 6d–f). When SB202190 pretreatment was applied a 
significant inhibition of IL-6 protein expression occurred 
Fig. 5. 12-O-tetradecanoylphorbol 13-acetate (TPA)-
induced IL-1β and IL-6 mRNA expression in p38β/δ 
knockout (KO) mice compared with wild-type (WT) 
mice. In two separate experiments 4-mm punch biopsies 
were obtained 2, 5 and 8 h post-challenge and interleukin 
(IL)-1β and IL-6 mRNA expressions were analysed by 
quantitative real-time reverse transcription polymerase 
chain reaction (real-time RT-PCR) and normalized to 
glyceraldehyde-3-phosphate dehydrogenase (gAPDH). 
In the first experiment two biopsies was obtained 2 h 
post-challenge from the left ear and another two biopsies 
was taken 5 h post-challenge from the right ear. In the 
second experiment only two biopsies 8 h post-challenge 
was obtained from each mouse. In each experiment the 
KO mice and WT mice were divided into the following 
groups: 3 mice received pretreatment with vehicle prior to 
challenge with vehicle. 10 mice received pretreatment with 
vehicle prior to challenge with TPA. Five mice received 
pretreatment with SB202190 prior to challenge with TPA. 
In all experiments pretreatment was applied topically 100 
min prior to challenge. The graphs show indexed values 
of mRNA expression compared with vehicle-pretreated 
and vehicle-challenged WT mice. (a) IL-1β, 2 h (b) IL-
1β, 5 h (c) IL-1β, 8 h (d) IL-6, 2 h (e) IL-6, 5 h (f) IL-6, 
8 h. Results are shown as back-transformed means with 
95% confidence intervals. Significant differences are 
marked *p < 0.0001 (compared with vehicle); **p < 0.0001 
(compared with TPA). Note that the y-axes have different 
scales in each sub-figure.
Fig. 6. 12-O-tetradecanoylphorbol 13-acetate (TPA)-
induced IL-1β and IL-6 protein expression in p38β/δ 
knockout (KO) mice and wild-type (WT) mice. In three 
separate experiments mouse ears were collected 5, 8 and 
24 h post-challenge immediately after the mouse was 
sacrificed and IL-1β and IL-6 protein expression was 
determined by enzyme-linked immunoassay (ELISA). 
In each experiment the KO mice and WT mice were 
divided into the following groups: 3 mice received 
pretreatment with vehicle prior to challenge with vehicle. 
Ten mice received pretreatment with vehicle prior to 
challenge with TPA. Five mice received pretreatment 
with SB202190 prior to challenge with TPA. In all 
experiments pretreatment was applied topically 100 min 
prior to challenge. (a) IL-1β, 5 h (b) IL-1β, 8 h (c) IL-1β, 
24 h (d) IL-6, 5 h (e) IL-6, 8 h (f) IL-6, 24 h. Results are 
shown as back-transformed means with 95% confidence 
intervals. Significant differences are marked *p < 0.0001 
(compared with vehicle); **p < 0.0036 (compared with 
TPA); ***p < 0.0001 (compared with TPA); ▲p = 0.0003; 
▲▲p = 0.022. Note that the y-axes have different scales 
in each sub-figure.
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in both mouse groups (p < 0.0001). As seen with IL-1β, 
a significantly higher expression level of IL-6 protein 
was seen in WT mice compared with KO mice 8 h after 
challenge with TPA (p = 0.022).
DISCUSSION
While p38β KO and p38δ KO mice have been described 
previously (24, 25), p38β/δ double KO mice were ge-
nerated for the first time in this study. p38β/δ KO mice 
were viable and fertile and they developed normally. 
p38β has been shown to play a role in keratinocytes 
in response to stress and inflammation, whereas p38δ 
may play a role in keratinocyte differentiation (17) and 
p38δ has also been shown to be essential for skin tumour 
development in mice (28). 
Several mouse models have been established to study 
skin inflammation (29) including various delayed allergy 
reactions and different non-allergic toxic skin inflam-
matory models. In this study the role of the various p38 
isoforms were studied in a non-allergic TPA-induced 
skin inflammation model using both p38β/δ KO mice 
and WT control mice.
TPA application resulted in a significant increase in 
ear thickness and neutrophil cell infiltration in both WT 
and KO mice and pretreatment with the p38α/β inhibitor, 
SB202190, before TPA application resulted in a signi-
ficant inhibition of the inflammatory response in both 
mouse groups. However, a significant slower onset but 
prolonged duration of the TPA-induced inflammatory 
response was seen in p38β/δ KO mice compared with 
WT mice, and this was paralleled by a significant lower 
IL-1β and IL-6 protein expression in p38β/δ KO mice 
compared with WT mice 8 h after TPA application, whe-
reas no differences were seen at 24 h. The reason why 
the IL-1β and IL-6 protein expression was significantly 
reduced in the KO mice at 8 h, but only insignificantly 
reduced at 5 h, is probably due to the fact, that the pro-
tein expression at 8 h were substantially higher, which 
makes the difference easier to detect.
Normal epidermal keratinocytes express p38α, p38β 
and p38δ (12, 16). p38γ has not been detected in kerati-
nocytes or inflammatory cell lineages (6, 12, 16) and is 
unlikely to play a role in skin inflammation although p38γ 
expression has been demonstrated in human fibroblasts 
(30). p38α is therefore the dominating p38 isoform in 
the epidermis of p38β/δ KO mice and when the p38α/β 
inhibitor, SB202190, was applied to the skin of p38 β/δ 
KO mice before TPA challenge, p38γ was the only active 
p38 isoform present. The maximal inflammatory response 
obtained 8 h after TPA application was similar in p38β/δ 
KO mice and WT mice. Furthermore, the inhibition of the 
inflammatory response after pretreatment with SB202190 
was similar in the two groups. This allows us to conclude 
that the p38α is the most important p38 isoform in skin 
inflammation which is also in accordance with previous 
reports (22). Homozygous p38α KO mice are not viable 
(20), whereas homozygous p38β KO mice were viable 
and p38β KO mice were shown to have a normal acti-
vation of p38 in response to cellular stress and a normal 
lipopolysaccharide-induced cytokine production (24). 
In contrast, homozygous p38α KO embryonic stem cells 
showed no IL-6 production in response to IL-1 stimu-
lation (20), supporting a dominating role of the p38α 
isoform in an inflammatory response. Using a contact hy-
persensitivity model, heterozygous p38α KO mice were 
also shown to have reduced 1-fluoro-2,4-dinitrobenzene 
(DNFB)-induced ear swelling and infiltration of cells 
compared with WT mice (14). 
The dominating role of p38α in eliciting inflammatory 
responses is not limited to the skin. A dominating role of 
p38α in collagen-induced arthritis in mice has also been 
demonstrated (23). These results are consistent with our 
findings and indicate a key role of p38α in inflammatory 
responses in general. Our data also demonstrate a minor 
role of p38β and/or δ in the TPA-induced inflammatory 
response. A significant slower onset, but prolonged du-
ration, of the TPA-induced inflammatory response was 
seen in p38β/δ KO mice compared with WT mice, and 
this difference between KO and WT mice was maintai-
ned when both p38α and β were inhibited by SB202190, 
suggesting a role of p38δ in this response, although our 
results cannot exclude that the observed changes seen in 
the KO mice is the net result of opposite responses of p38 
β and δ. Opposite regulatory effects of p38 isoforms have 
been demonstrated previously (31). However, it is also 
possible, that application of SB202190 did not result in 
complete inhibition of p38α and β, and therefore, a role of 
p38β cannot be excluded. Schindler et al. (28) have shown 
previously that loss of p38δ prevented TPA-induced epi-
dermal hyperproliferation and lead to reduced ERK and 
AP-1 activation supporting a role of this p38 isoform in 
TPA-induced inflammatory responses. Although a definite 
conclusion cannot be drawn based on the data presented 
here, our observation indicates a dual activity of p38β and/
or δ in the inflammatory response. In the initial phase of 
an inflammatory response p38β and/or δ seem to exert 
pro-inflammatory activity, whereas a role in terminating 
the inflammatory response may be dominating in the later 
stages. Interestingly, a dual activity in an inflammatory 
response has previously been demonstrated for p38α (22) 
as well as for the p38α downstream kinase MSK1 and 
2 (32). The slower onset of the inflammatory response 
seen in p38 β/δ KO mice can in part be explained by 
the decreased IL-1β protein expression seen after 8 h. 
Because no differences between p38β/δ KO and WT 
mice were seen in IL-1β mRNA expression at any time-
points, our data indicate a role of p38β and/or δ in the 
post-transcriptional regulation of IL-1β expression.
Our results, together with previously published data 
demonstrating a dual activity of the p38 isoforms, 
illustrate the need for a deeper understanding of the 
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signalling pathways that control the expression of pro-
inflammatory cytokines and how they are integrated in 
the inflammatory process in order to point out which 
kinases are likely to be the best therapeutic targets. 
It is indisputable that the p38 signalling pathway plays 
an important role in eliciting inflammatory responses, 
but kinases downstream of p38 may turn out to be better 
drug targets. It is important to consider these questions 
when planning future strategies for pharmacological 
inhibition of the p38 signalling pathway.
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